Improving heart disease prevention after a pregnancy with high blood pressure
Official title: Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
Run by University of Utah · NCT05826925 · Data updated 2026-11-12
We will test a patient decision aid to help women who had high blood pressure during pregnancy learn about and take steps to prevent heart disease after delivery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT05826925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women who delivered at the University of Utah with a pregnancy complicated by a hypertensive disorder, who can read and speak English or Spanish, and who do not have prior cardiovascular disease are ideal candidates.
✕Probably not a fit
Women with existing cardiovascular disease or with cognitive or vision impairments that prevent using the decision aid are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Women who experience hypertensive disorders of pregnancy have about twice the later-life risk of cardiovascular disease, and early postpartum interventions may improve long-term heart health. This pilot will deliver a patient-centered decision aid in the postpartum period to try to increase knowledge and self-efficacy for cardiovascular prevention. The study will enroll English- or Spanish-speaking women who delivered at the University of Utah and exclude those with prior cardiovascular disease or impairments that prevent use of the aid. Primary outcomes are feasibility and preliminary effects on patient knowledge, self-efficacy, and engagement in preventive care.
Why it matters
Potential benefit: If successful, the decision aid could help postpartum women better understand their heart disease risk and take preventive steps earlier.
How similar studies have gone: Decision aids have improved knowledge and decision-making in other clinical settings, but patient-centered interventions specifically for postpartum women after hypertensive pregnancies are limited and largely untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Delivered a pregnancy complicated by a hypertensive disorder of pregnancy at the University of Utah during the current hospital admission * Ability to speak and read English or Spanish * Written informed consent obtained Exclusion Criteria: * Cardiovascular disease diagnosis (history of peripheral artery disease, stroke, or myocardial infarction) * Impairment of cognitive function or vision that prohibits communication and/or reading the decision aid.
Where it's running
-
University of Utah Hospital
Salt Lake City, Utah, United States Recruiting
Study contacts
- Study coordinator: Lauren Theilen, MD
- Email: lauren.theilen@hsc.utah.edu
- Phone: 801-581-8425
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy
This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.
-
Postpartum program to prevent cardiometabolic problems after preeclampsia
This study will test a 9-month app-based support program to lower blood pressure and help with weight loss in first-time mothers who recently had preeclampsia.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.